Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Clinical Immunology

Long-Term Surveillance and Daily Management

At a Glance

Long-term care for ICOSLG deficiency is individualized: monitor lung function and infections, track blood counts, immune-cell and antibody (IgG) levels, examine persistent skin lesions, follow vaccine precautions, and keep a written fever plan with your immunologist.

Managing ICOSLG deficiency is a lifelong process of “active surveillance.” Because this condition is exceptionally rare, there are no universal, one-size-fits-all schedules for testing. Instead, your care team will tailor a plan based on your unique history of infections and how your body responds to treatment [1][2].

Long-Term Respiratory Monitoring

Preventing permanent lung damage is a top priority. Recurrent infections can lead to bronchiectasis, a condition where the airways become permanently widened and scarred, making it even harder to clear mucus [3].

  • Lung Function Tests: You may have baseline spirometry (a test that measures how much and how fast you can breathe out) and other pulmonary function tests. These are repeated based on age and symptoms [4][5].
  • Imaging: High-resolution CT scans are the most sensitive way to find early signs of bronchiectasis. Because of radiation concerns, these are not usually done on a fixed, routine schedule. Instead, follow-up imaging is considered when bronchiectasis is suspected, your symptoms change, or your lung function tests decline [3][6].
  • Sputum Checks: If you develop a productive cough (coughing up mucus), your doctor may collect a sample to see exactly which bacteria are present. This helps ensure you are using the most effective antibiotic and monitors for resistant germs [7][8].

Tracking Your “Immune Blueprint”

Regular blood work helps your immunologist see if your condition is stable or if your treatment needs adjustment.

  • Complete Blood Count (CBC): This monitors your Absolute Neutrophil Count (ANC). Because the reported case included moderate neutropenia, tracking these numbers helps your team understand your risk for bacterial infections [9][10].
  • Lymphocyte Subsets: Periodic tests of your T-cell and B-cell levels—including your switched-memory B cells—provide a “snapshot” of your immune system’s health [11][12].
  • IgG Trough Levels: If you are on Immunoglobulin Replacement Therapy, your “trough” level (the level of IgG in your blood just before your next dose) will be checked. Lower levels are often linked to a higher risk of needing antibiotics [13].

Skin and Viral Vigilance

Because of your susceptibility to DNA viruses, you and your care team must be proactive about skin health.

  • HPV and HSV Checks: You should regularly inspect your skin and mucosal surfaces. Persistent or atypical warts or cold sores warrant examination and possibly biopsy. Any intensified cervical, anal, genital, or dermatologic surveillance must be individualized; routine swabbing is not the same as evaluating a persistent lesion. It is important to note that an established HPV-associated cancer risk has not been proven specifically for ICOSLG deficiency [14][15].
  • Biopsies: If a skin lesion is persistent or looks unusual, a biopsy may be needed to rule out infection or other complications [16].

Daily Life and Risk Management

Living with a combined immunodeficiency requires balancing safety with quality of life.

  • Infection Control: Standard precautions like frequent handwashing and avoiding close contact with people who are actively sick are essential. However, complete isolation is often not recommended, as social participation is vital for mental health [17].
  • Vaccination: Inactivated (non-live) vaccines are generally safe, but they may produce a reduced or uncertain immune response. Immunoglobulin therapy can also complicate the interpretation of antibody titers, but non-live HPV vaccination remains a discussion point [18]. Live vaccines (like MMR or chickenpox) may be contraindicated in significant combined immunodeficiency and should never be given without explicit clearance from the treating immunologist [19].
  • Emergency Planning: You should have a printed, individualized “fever plan” from your doctor specifying the exact temperature threshold, your baseline ANC, who to call, and whether to go directly to emergency care. Do not wait for a persistent fever to seek care [20][21].

Psychosocial Health

Rare diseases can be taxing. Studies in similar immune deficiencies show that concern about infections can lead to anxiety or depression [22]. Discussing these feelings with your care team is just as important as discussing your blood counts. Many patients find that moving to home-based therapy (like SCIG) improves their sense of control and reduces the time spent in medical settings [23][24].

Common questions in this guide

How often should I have lung tests for ICOSLG deficiency?
Your immunologist should set the schedule based on your age, symptoms, infection history, and lung function. Spirometry or other pulmonary function tests may be repeated over time, while high-resolution CT is generally reserved for suspected bronchiectasis, changing symptoms, or declining lung function rather than a fixed routine schedule.
Which blood tests are used to monitor ICOSLG deficiency?
A complete blood count can track your absolute neutrophil count, and lymphocyte-subset testing can measure T cells, B cells, and switched-memory B cells. If you receive immunoglobulin replacement, your IgG trough level may be checked before a dose to help assess whether treatment is adequate.
What should I do if I develop a fever with ICOSLG deficiency?
Use the written fever plan made by your doctor, which should state the temperature threshold, your baseline ANC, who to call, and when to go to emergency care. Do not wait for a fever to persist before seeking advice, because neutropenia and combined immunodeficiency can increase infection risk.
Are vaccines safe with ICOSLG deficiency?
Non-live vaccines are generally considered safe, but your immune response may be reduced or uncertain, and immunoglobulin therapy can affect antibody-test interpretation. Live vaccines such as MMR or chickenpox may be unsafe in significant combined immunodeficiency and should be given only after explicit clearance from your treating immunologist.
Should persistent warts or skin lesions be checked?
Yes. Persistent or unusual warts, cold sores, or other skin or mucosal lesions should be examined by a clinician and may require a biopsy to distinguish infection from other complications. Cervical, anal, genital, or skin surveillance should be individualized; a specific HPV-associated cancer risk has not been proven for ICOSLG deficiency.
How can I lower infection risk without giving up daily activities?
Frequent handwashing and avoiding close contact with people who are actively ill can reduce exposure. Complete isolation is usually not recommended, so your plan should balance infection precautions with school, work, social participation, and mental health; home-based SCIG may make treatment easier for some people.

Get notified when new evidence is published on Late-onset combined immunodeficiency due to ICOSL deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    Loss of human ICOSL results in combined immunodeficiency.

    Roussel L, Landekic M, Golizeh M, et al.

    The Journal of experimental medicine 2018; (215(12)):3151-3164 doi:10.1084/jem.20180668.

    PMID: 30498080
  2. 2

    Primary immunodeficiency.

    McCusker C, Upton J, Warrington R

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14(Suppl 2)):61 doi:10.1186/s13223-018-0290-5.

    PMID: 30275850
  3. 3

    Evaluation of pulmonary findings in patients with humoral immunodeficiency.

    Karalı Z, Karalı Y, Çekiç Ş, et al.

    Turk pediatri arsivi 2020; (55(2)):174-183 doi:10.14744/TurkPediatriArs.2020.46656.

    PMID: 32684763
  4. 4

    Pulmonary manifestations in a cohort of patients with inborn errors of immunity: an 8-year follow-up study.

    Movahedi M, Jamee M, Ghaffaripour H, et al.

    Allergologia et immunopathologia 2022; (50(1)):80-84 doi:10.15586/aei.v50i1.388.

    PMID: 34935317
  5. 5

    Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency.

    Smits BM, Boland SL, Hol ME, et al.

    The journal of allergy and clinical immunology. In practice 2024; (12(4)):1037-1048.e3 doi:10.1016/j.jaip.2023.12.047.

    PMID: 38182096
  6. 6

    Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

    Schütz K, Alecsandru D, Grimbacher B, et al.

    Journal of clinical immunology 2019; (39(1)):45-54 doi:10.1007/s10875-018-0577-9.

    PMID: 30547383
  7. 7

    Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease.

    Cutajar J, Gkrania-Klotsas E, Sander C, et al.

    The journal of allergy and clinical immunology. Global 2023; (2(4)):100133 doi:10.1016/j.jacig.2023.100133.

    PMID: 37781665
  8. 8

    Antibiotic resistance, bacterial transmission and improved prediction of bacterial infection in patients with antibody deficiency.

    Rofael S, Leboreiro Babe C, Davrandi M, et al.

    JAC-antimicrobial resistance 2023; (5(6)):dlad135 doi:10.1093/jacamr/dlad135.

    PMID: 38098890
  9. 9

    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.

    Cornelissen HM, Musekwa EM, Glashoff RH, et al.

    British journal of haematology 2022; (198(5)):875-886 doi:10.1111/bjh.18337.

    PMID: 35791731
  10. 10

    Can we identify WHIM in infancy? Opportunities with the public newborn screening process.

    Yilmaz M, Potts DE, Geier C, Walter JE

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(2)):215-221 doi:10.1002/ajmg.c.32002.

    PMID: 36210583
  11. 11

    Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs.

    Framme JL, Lundqvist C, Lundell AC, et al.

    Journal of clinical immunology 2022; (42(3)):618-633 doi:10.1007/s10875-021-01201-5.

    PMID: 35080750
  12. 12

    Shorter birth length and decreased T-cell production and function predict severe infections in children with non-severe combined immunodeficiency cartilage-hair hypoplasia.

    Pello E, Kainulainen L, Vakkilainen M, et al.

    The journal of allergy and clinical immunology. Global 2024; (3(1)):100190 doi:10.1016/j.jacig.2023.100190.

    PMID: 38187867
  13. 13

    Immunoglobulin G Trough Levels and Infection Risk in Adults with Inborn Errors of Immunity Receiving Immunoglobulin Therapy.

    Aktaş ÖÖ, Özer NO, Kaplankıran C, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(9)) doi:10.3390/medicina61091549.

    PMID: 41010940
  14. 14

    Case Report: Altered NK Cell Compartment and Reduced CXCR4 Chemotactic Response of B Lymphocytes in an Immunodeficient Patient With HPV-Related Disease.

    Doria M, Moscato GMF, Di Cesare S, et al.

    Frontiers in immunology 2022; (13()):799564 doi:10.3389/fimmu.2022.799564.

    PMID: 35154113
  15. 15

    Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

    Béziat V

    Human genetics 2020; (139(6-7)):919-939 doi:10.1007/s00439-020-02183-x.

    PMID: 32435828
  16. 16

    Cutaneous Findings in Inborn Errors of Immunity: An Immunologist's Perspective.

    Cagdas D, Ayasun R, Gulseren D, et al.

    The journal of allergy and clinical immunology. In practice 2023; (11(10)):3030-3039 doi:10.1016/j.jaip.2023.06.037.

    PMID: 37391021
  17. 17

    Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity.

    Yorgun Altunbas M, Sefer AP, Bilgic-Eltan S, et al.

    Journal of clinical immunology 2026; (46(1)):18 doi:10.1007/s10875-025-01972-1.

    PMID: 41493669
  18. 18

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  19. 19

    Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.

    van Leeuwen LPM, GeurtsvanKessel CH, Ellerbroek PM, et al.

    The Journal of allergy and clinical immunology 2022; (149(6)):1949-1957 doi:10.1016/j.jaci.2022.04.002.

    PMID: 35421449
  20. 20

    [HOW TO APPROACH A PATIENT WITH SUSPECTED IMMUNODEFICIENCY].

    Toker O, Aggmon-Levin N, Somech R

    Harefuah 2016; (155(3)):170-6, 195.

    PMID: 27305752
  21. 21

    Retrospective analysis of patients with severe combined immunodeficiency and alternative diagnostic criteria: A 20-year single centre experience.

    Korkmaz SB, Karaselek MA, Aytekin SE, et al.

    International journal of immunogenetics 2023; (50(4)):177-184 doi:10.1111/iji.12624.

    PMID: 37308802
  22. 22

    Frequency of depression and anxiety in patients with inborn errors of immunity: a cross-sectional study.

    Wolff LJ, Witte T, Kahl KG, et al.

    BMC psychiatry 2026; (26(1)).

    PMID: 42745244
  23. 23

    Immunoglobulin replacement therapy in patients with primary and secondary immunodeficiencies: impact of infusion method on immunoglobulin-specific perceptions of quality of life and treatment satisfaction.

    Mallick R, Hahn N, Scalchunes C

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2025; (21(1)):2 doi:10.1186/s13223-024-00939-y.

    PMID: 39773529
  24. 24

    Health-Related Quality of Life in Adult Patients with Common Variable Immunodeficiency Disorders and Impact of Treatment.

    Rider NL, Kutac C, Hajjar J, et al.

    Journal of clinical immunology 2017; (37(5)):461-475 doi:10.1007/s10875-017-0404-8.

    PMID: 28536745

This page explains long-term monitoring and daily management for ICOSLG deficiency for informational purposes only and does not replace medical advice. Your immunologist should tailor testing, vaccines, infection precautions, and fever instructions to your situation.